NHC vs. PACS, SYRE, LGND, AVDL, TARS, WRBY, DVAX, ESTA, MORF, and INMD
Should you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include PACS Group (PACS), Spyre Therapeutics (SYRE), Ligand Pharmaceuticals (LGND), Avadel Pharmaceuticals (AVDL), Tarsus Pharmaceuticals (TARS), Warby Parker (WRBY), Dynavax Technologies (DVAX), Establishment Labs (ESTA), Morphic (MORF), and InMode (INMD). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and National HealthCare (NYSE:NHC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.
In the previous week, PACS Group had 23 more articles in the media than National HealthCare. MarketBeat recorded 26 mentions for PACS Group and 3 mentions for National HealthCare. PACS Group's average media sentiment score of 0.48 beat National HealthCare's score of 0.25 indicating that National HealthCare is being referred to more favorably in the news media.
PACS Group received 10 more outperform votes than National HealthCare when rated by MarketBeat users.
National HealthCare has a net margin of 6.95% compared to National HealthCare's net margin of 0.00%. PACS Group's return on equity of 6.28% beat National HealthCare's return on equity.
56.4% of National HealthCare shares are held by institutional investors. 13.8% of National HealthCare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
National HealthCare has higher revenue and earnings than PACS Group.
PACS Group presently has a consensus price target of $31.00, indicating a potential upside of 9.89%. Given National HealthCare's higher probable upside, analysts plainly believe PACS Group is more favorable than National HealthCare.
Summary
National HealthCare beats PACS Group on 7 of the 11 factors compared between the two stocks.
Get National HealthCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for NHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National HealthCare Competitors List
Related Companies and Tools
